HIV

Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression
Endpoints
Mon, 03/8/21 - 11:04 am
Gilead Sciences
Biktarvy
HIV
Exclusive: After four decades, one researcher's radical HIV cure finally gets its shot
Endpoints
Wed, 02/17/21 - 10:45 am
Kamel Khalili
HIV
Excision BioTherapeutics
Incyte makes bid to join the checkpoint inhibitor club
Pharmaforum
Tue, 02/2/21 - 10:25 am
Incyte
FDA
retifanlimab
anal cancer
HIV
HPV
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
BioPharma Dive
Mon, 02/1/21 - 10:48 am
Gilead Sciences
HIV
Gritstone Oncology
drug development
FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo
RAPS.org
Thu, 01/28/21 - 10:49 am
FDA
Cabenuva
HIV
ViiV
Aurinia
Lupkynis
Merck
Verquvo
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
Sun, 01/24/21 - 03:24 pm
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
FDA approves first monthly injectable to treat HIV infection
Stat
Thu, 01/21/21 - 11:45 pm
ViiV
FDA
Cabenuva
HIV
Fierce Pharma's top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches
Fierce Pharma
Wed, 12/23/20 - 10:51 am
pharma marketing
drug pricing
COVID-19
pandemic
remdesivir
Gilead Sciences
HIV
PrEP
Pfizer
Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir
Pharmaforum
Thu, 11/19/20 - 10:18 am
Gilead Sciences
lenacapavir
HIV
GSK and ViiV score breakthrough therapy designation in HIV prevention, as Truvada showdown draws nearer
Endpoints
Tue, 11/17/20 - 11:12 pm
GSK
ViiV
FDA
cabotegravir
HIV
PrEP
GSK’s ViiV Healthcare caps virtual HIV summit with a Facebook Live cabaret
Fierce Pharma
Sat, 11/14/20 - 09:56 pm
GSK
ViiV
HIV
Facebook
drug marketing
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
Endpoints
Mon, 11/9/20 - 11:56 am
GSK
ViiV
cabotegravir
HIV
PrEP
FDA
Gilead announces new data on Biktarvy for the treatment of HIV in Black Americans
Pharmaceutical Business Review
Thu, 10/22/20 - 11:04 am
Gilead Sciences
Biktarvy
HIV
GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen
Fierce Pharma
Mon, 10/5/20 - 11:45 am
GSK
ViiV
Dovato
HIV
Gilead got a boost from a newly approved PrEP drug. Now, a major insurer is dropping coverage
MedCity News
Fri, 08/14/20 - 12:01 am
Gilead Sciences
UnitedHealthcare
PrEP
HIV
Descovy
Truvada
Moderna to open COVID-19 vaccine trials to people with HIV
Beckers Hospital Review
Sat, 08/8/20 - 10:52 pm
Moderna Therapeutics
clinical trials
mRNA-1273
vaccines
HIV
ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato
Pharmaceutical Business Review
Fri, 08/7/20 - 10:40 am
ViiV Healthcare
FDA
HIV
Dovato
HIV-1
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
Endpoints
Wed, 07/29/20 - 12:41 pm
GSK
R&D
COPD
HIV
cancer
CytoDyn shares slammed as BLA filing for leronlimab in HIV hits a wall
Endpoints
Mon, 07/13/20 - 12:17 pm
CytoDyn
leronlimab
HIV
FDA
After going ‘crazy’ over the science, Merck signs up a new partner in the hunt for an HIV cure
Endpoints
Mon, 07/13/20 - 11:09 am
Merck
Dewpoint Therapeutics
HIV
R&D

Pages